Fras-le S.A (FRAS3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 27.77 |
|---|---|
| 52-week range | 19.11 – 28.47 |
| Return, 1 month / 3 months | +18.4% / +35.5% |
| Return, 1 year / 3 years | +28.4% / +99.6% |
| Trend | Uptrend |
| RSI (14) | 76 |
| Volatility (1 year) | 28.7% |
| Worst drawdown (1 year) | -24.2% |
| Average daily value traded | 5.82M BRL |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fras-le S.A is a Brazilian maker of friction materials and automotive components based in Caxias do Sul. It produces brake pads, brake linings, discs and related parts for cars, trucks, buses and trailers, along with friction materials for industrial uses. The company supplies vehicle manufacturers and also serves the replacement parts market, selling its products in Brazil and abroad through distributors and parts dealers.
On this site Fras-le S.A appears as a stock on the Sao Paulo Exchange (Brazil), code FRAS3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fras-le S.A (FRAS3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 27.77 on 16 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 72 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 28.4% and over the last three months it rose 35.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.9% | ||
| From 52-week high | -1.7% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 35.5% | ||
| 6-month return | 27.5% | ||
| 12-month return, skipping the last month | 8.4% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.2% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 5.82M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | +18.4% |
| 3 months | +35.5% |
| 6 months | +27.5% |
| 1 year | +28.4% |
| 3 years | +99.6% |
| 5 years | +126.0% |
Signals
| 50-day / 200-day average | 23.48 / 22.42 |
|---|---|
| Golden / death cross (60 days) | Golden, 10 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jul 2026 | BRL 0.2516 |
| 16 Dec 2025 | BRL 0.3693 |
| 4 Jul 2025 | BRL 0.3403 |
| 19 Dec 2024 | BRL 0.2727 |
| 22 Jul 2024 | BRL 0.2459 |
| 22 Apr 2024 | BRL 0.1321 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.